Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
When NNMT activity is reduced, cells can more efficiently utilize nicotinamide adenine dinucleotide (NAD+), leading to enhanced mitochondrial function and improved metabolic flexibility
Human data: caution The only human data published to date are extremely limited: a 2024 pilot trial in 12 patients with interstitial cystitis treated with 10 mg of BPC-157 injected into the bladder wall, and a 2026 pharmacokinetic study in two healthy subjects (one 58-year-old man and one 68-year-old woman) receiving intravenous BPC-157
Otvos, L.J., Cudic, M., Chua, B.Y., Deliyannis, G., and Jackson, D.C., Mol
doi: 10.1038/clpt.2010.67 [DOI] [PubMed] [Google Scholar] 61.Hansen HH, Hansen G, Tang-Christensen M, Larsen PJ, Axel AMD, Raben A, et al
Trigger neurologic symptoms, such as numbness and tingling in hands and feet, mood changes, anxiety, difficulty walking, disorientation, and memory loss
A full certificate of analysis (COA) is included with each order, ensuring complete transparency for dual GIP/GLP-1 receptor agonist research
US$ 22.68
US$ 24.62
US$ 25.10
US$ 26.92
US$ 28.38
US$ 28.55
